Kim et al., 2000 - Google Patents
DNA vaccines encoding viral glycoproteins induce nonspecific immunity and Mx protein synthesis in fishKim et al., 2000
View PDF- Document ID
- 16160480574055122956
- Author
- Kim C
- Johnson M
- Drennan J
- Simon B
- Thomann E
- Leong J
- Publication year
- Publication venue
- Journal of virology
External Links
Snippet
Protective immunity by vaccination with plasmid DNA encoding a viral glycoprotein (G) has long been assumed to result from the induction of a specific immune response. We report here that the initial protection may be due to the induction of alpha/beta interferon, with long …
- 241000251468 Actinopterygii 0 title abstract description 130
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
- A61K2039/55527—Interleukins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/21—Retroviridae, e.g. equine infectious anemia virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kim et al. | DNA vaccines encoding viral glycoproteins induce nonspecific immunity and Mx protein synthesis in fish | |
| Jørgensen et al. | CpG DNA induces protective antiviral immune responses in Atlantic salmon (Salmo salar L.) | |
| Ding et al. | Protective immunity against Eimeria acervulina following in ovo immunization with a recombinant subunit vaccine and cytokine genes | |
| Lorenzen et al. | Protective immunity to VHS in rainbow trout (Oncorhynchus mykiss, Walbaum) following DNA vaccination | |
| Handman | Leishmaniasis: current status of vaccine development | |
| JP4484904B2 (en) | Immunization by inoculation with DNA transcription unit | |
| Dhama et al. | DNA vaccines and their applications in veterinary practice: current perspectives | |
| Lillehoj et al. | Resistance to intestinal coccidiosis following DNA immunization with the cloned 3-1E Eimeria gene plus IL-2, IL-15, and IFN-γ | |
| Kanellos et al. | DNA vaccination can protect Cyprinus Carpio against spring viraemia of carp virus | |
| Cazorla et al. | Oral vaccination with Salmonella enterica as a cruzipain-DNA delivery system confers protective immunity against Trypanosoma cruzi | |
| Babiuk et al. | Immunization of animals: from DNA to the dinner plate | |
| Weiss et al. | Genetic vaccination against malaria infection by intradermal and epidermal injections of a plasmid containing the gene encoding the Plasmodium berghei circumsporozoite protein | |
| Scheerlinck et al. | The immune response to a DNA vaccine can be modulated by co-delivery of cytokine genes using a DNA prime-protein boost strategy | |
| Lorenzen et al. | DNA vaccination of rainbow trout against viral hemorrhagic septicemia virus: a dose–response and time–course study | |
| Babiuk et al. | Nucleic acid vaccines: research tool or commercial reality | |
| Ichino et al. | Factors associated with the development of neonatal tolerance after the administration of a plasmid DNA vaccine | |
| Hwang et al. | Montanide IMS 1312 VG adjuvant enhances the efficacy of immersion vaccine of inactivated viral hemorrhagic septicemia virus (VHSV) in olive flounder, Paralichthys olivaceus | |
| Smooker et al. | Humoral responses in mice following vaccination with DNA encoding glutathione S‐transferase of Fasciola hepatica: effects of mode of vaccination and the cellular compartment of antigen expression | |
| Fry et al. | Gene gun DNA immunization of cattle induces humoral and CD4 T-cell-mediated immune responses against the Theileria parva polymorphic immunodominant molecule | |
| Alves et al. | Innate immune defenses induced by CpG do not promote vaccine-induced protection against foot-and-mouth disease virus in pigs | |
| CA2702534C (en) | A multicomponent or monocomponent vaccine to be used against chagas disease, pharmaceutical compositions containing them, procedure for the obtention of immunogen of said vaccines, and nucleic acid used in said procedure | |
| Gerdts et al. | Recent advances in the use of DNA vaccines for the treatment of diseases of farmed animals | |
| Fowler et al. | Progress in the development of DNA vaccines against foot-and-mouth disease | |
| Jin et al. | Induction of active immune suppression by co-immunization with DNA-and protein-based vaccines | |
| LaPatra et al. | The dose-dependent effect on protection and humoral response to a DNA vaccine against infectious hematopoietic necrosis (IHN) virus in subyearling rainbow trout |